An oncogenic role of SRPK1/2 (Serine/arginine-protein kinase) was reported in various types of tumors, including leukemia and melanoma as well as pancreatic, breast, colon, lung, and ovarian cancer [59], hence different strategies have been proposed for the SRPK1/2 suppression [60]. Here, SRPK1 is linked to melanoma.